ARTICLE | Distillery Therapeutics
Cancer
July 25, 2017 8:34 PM UTC
Cell culture and mouse studies suggest nanoparticles loaded with siRNAs targeting SOX2, OLIG2, SALL2, and POU3F2 could help treat the proneural subtype of glioblastoma multiforme (GBM). In two proneu...